MedTrace Logo

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

NCT06002945 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-12-10

No results posted yet for this study

Summary

The goal of this prospective observational study is to create a network repository of clinical data and biological samples to help researchers learn more about myasthenia gravis.

Conditions

Interventions

OTHER

Blood sample

Each blood draw will involve removing approximately 75 mL (5 tablespoons) of blood

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Richard Nowak, MD · Yale University

  • Vern Juel, MD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-12
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06002945 on ClinicalTrials.gov